- Responding to COVID-19
- Message from the Director
- Board Chair and Vice Chairs
- Leadership
- Sylvester by the Numbers
-
- Internationally Known Eye Cancer Researcher Joins Sylvester and Bascom Palmer
- Dr. Macarena de la Fuente Named Neuro-Oncology Clinical Service Leader and Chief of Neuro-Oncology Division
- World-Renowned Multiple Myeloma Expert Joins Sylvester Leadership
- Storyteller Will Help Sylvester Write Next Chapter in Hematology
- New Physicians and Researchers
-
- NCI Grant Funds Disparities and Equity Training Project at Sylvester
- Sylvester Receives NCI Supplement Award for CATCH-UP.2020
- NCI Grant Funds Study of Combination Therapy for Pancreatic Cancer
- Sylvester Researchers Receive Grants From the State of Florida
- Breast Cancer Researcher Receives Grant from the V Foundation and Miami Dolphins
- Sylvester Urologic Researcher Receives AUA Funding for Two-Year Research Project
-
- Artificial Intelligence Provides Game-Changing Intraoperative Brain Tumor Diagnostics
- First Single-Cell Analysis of Uveal Melanoma
- Deciphering Genetics by Studying GI Cancer Patients with “Extreme Outlier” Outcomes
- Targeted Chemotherapy for Treatment-Resistant Tumor Cells
- New Anti-Cancer Strategy Uses RNA to Ferry Chemo into Tumors
- Sylvester Urologist Leads Collaborative Study on Fertility Counseling Prior to Chemotherapy
- Culturally Relevant Programs Needed to Help End Hep B in Black Communities, Sylvester Researchers Report
- Positive Results for New Treatment Strategy for Localized Prostate Cancer
- Nanoparticle Delivery Can Enhance Chemotherapy for Aggressive Lymphomas
- Sylvester Study Contributed to FDA Approval of Targeted Therapy for Lung Cancer
- Waking Cancer Cells to Eliminate Them
-
- Sylvester Opens the Dwoskin Proton Therapy Center
- Sylvester Researcher Wins International Award for Discoveries Leading to Advances in Immunotherapy
- Dr. Erin Kobetz Named Vice Chair of State Advisory Council
- Dr. Krishna Komanduri Welcomed into Prestigious Society for Immunologists
- Sylvester Oncologist Receives Women in Sarcoma Award
- Sylvester’s Radiation Oncology Team Earns Prestigious Press Ganey Award
- Sylvester Surgeon Receives Prestigious Research Fellowship
- Dr. Donna Lundy Wins Prestigious Award from American Cancer Society
- 2020 Zubrod Memorial Lecture and Outstanding Faculty Awards
- Cancer Survivorship
-
- Transformational $126 Million Gift Propels Sylvester into New Chapter of Excellence
- The Dolphins Challenge Cancer: A Decade of the DCC Ushers in a New Era of Fundraising
- Braman Family Foundation Renews Commitment to Fight Breast Cancer
- Woman’s Cancer Association Continues Legacy of Support to Sylvester
- Philanthropy During the COVID-19 Pandemic
71st
NCI-Designated Cancer Center in the Country.
1 of 2
NCI-Designated cancer centers in Florida.
365
Physicians and scientists devoted exclusively to cancer care and research.
1,759
Stem cell transplants & T-cell Therapies completed since program's inception.
1,650
Patients participating in 251 clinical studies (interventional and non-interventional).
9
Treatment facilites across South Florida.
13
Cancer site disease groups.
37
13 cancer support services and 24 cancer support groups.
8,500
Newly diagnosed cancer patients treated (CY 2019).
5,141
New patients (analytic cases - CY 2019).
394
Cancer relevant peer-reviewed publications, 111 with other NCI-Designated cancer centers.
$50.5M
Peer-reviewed and non-peer-reviewed funding for 310 active cancer projects:
$25.8M peer-reviewed
($9M from NCI)
$2.8M for training grants (additional)
